Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil PCIA after hip surgery in elderly patients
ChiCTR2600135573Phase 4Not yet recruiting
- Sponsor
- Taihe County Traditional Chinese Medicine Hospital
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine, sufentanil and flurbiprofen axetil in postoperative pain (2 arms), sponsored by Taihe County Traditional Chinese Medicine Hospital. Primary endpoint: Quality of postoperative recovery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tegileridinesufentanilflurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600135573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135573.